- Home
- IBG vs UPC Comparison
IBG vs UPC Comparison
Compare IBG & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBG | UPC |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | Australia | China |
| Employees | 9 | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 1.7M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | IBG | UPC |
|---|---|---|
| Price | $1.02 | $3.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 248.4K | 4.0K |
| Earning Date | 05-12-2026 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.30 | $2.00 |
| 52 Week High | $6.50 | $11.00 |
Technical Indicators
Market Signals| Indicator | IBG | UPC |
|---|---|---|
| Relative Strength Index (RSI) | 36.56 | 51.04 |
| Support Level | $0.97 | $2.67 |
| Resistance Level | $1.31 | $3.28 |
| Average True Range (ATR) | 0.10 | 0.31 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 6.52 | 58.35 |
Price Performance
Historical ComparisonAbout IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.
About UPC Universe Pharmaceuticals Inc.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.